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Case Report
Fatal cardiovascular instability secondary to
hypercalcaemia and intracellular calcium deposition
complicating T-cell leukaemia-lymphoma
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Lesson
Adult T-cell leukaemia-lymphoma is a rare haematological
malignancy, which can cause severe hypercalcaemia
and metastatic calcification resulting in life-threatening
arrhythmias.
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Case presentation
A 37-year-old Afro-Caribbean woman was admitted
with a three-week history of lethargy, myalgia and
intermittent chest pain. Her medical history consisted
only of an uncomplicated pregnancy. On admission,
she had acute kidney injury with severe hypercalcae-
mia (Ca2þ 4.74mmol/L) and proteinuria (Table 1).
Treatment with intravenous ﬂuids and empirical anti-
microbials to cover presumed sepsis were initiated.
She continued to deteriorate and was transferred to
the Intensive Care Unit (ICU) for respiratory support
and renal replacement therapy. The diﬀerential diag-
nosis was wide, including vasculitis, autoimmune dis-
ease, sepsis and malignancy, and the relevant tests
were requested.
A peripheral blood ﬁlm conﬁrmed leukocytosis
with a left shift but no abnormal cells. An auto-
immune screen, respiratory virus panel as well as
tests for human immunodeﬁciency virus and hepatitis
B and C antibodies were negative. Parathyroid hor-
mone (PTH) level was appropriately suppressed
(Table 1).
Four days after admission to the ICU, she devel-
oped recurrent episodes of both narrow- and broad-
complex tachycardia. An urgent echocardiogram
revealed poor global systolic function with no peri-
cardial eﬀusion or obvious valvular abnormality.
The corrected serum calcium concentration was
3.3mmol/L at this time. Treatment with DC cardio-
version and antiarrhythmics temporised the situation,
but the patient displayed marked sensitivity to both
amiodarone and lignocaine (leading to bradycardia)
and adrenaline (producing ventricular tachycardia).
Before a pacing wire could be placed, she had a
fatal brady-tachy arrhythmia with prolonged cardiac
arrest from which resuscitation was unsuccessful. At
the time of death, the underlying diagnosis was
unknown. At postmortem examination, the most
striking ﬁndings were:
(a) Intracellular calcium deposition in cardiac myo-
cytes (Figure 1);
(b) Widespread calciﬁcation in all medium- and
small-sized arteries including intra-renal arteries
with secondary micro-infarcts (Figure 1);
(c) Inﬁltration of lymph nodes, bone marrow, lung
and liver by large lymphoid blasts and features of
histiocytic haemophagocytosis. The lymphoid
blasts stained positively for CD3 and CD25
(Figure 2);
The parathyroid glands were histologically
normal. Antibodies to human T-cell lymphotropic
virus (HTLV) type 1 were positive consistent with
adult HTLV-related adult T-cell leukaemia-lym-
phoma (ATLL).
Discussion
Hypercalcaemia is a relatively common ﬁnding with
diverse aetiologies. While primary hyperparathyroid-
ism is the commonest worldwide cause, malignancy is
likely to be the most frequent aetiology in hospita-
lised patients in the United Kingdom.1 Cancer may
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produce elevations in calcium through osteoclast
activation, local oestolysis or generalised bone
resorption.
Symptoms are often indolent and non-speciﬁc,
including fatigue and anorexia with cardiac dys-
rhythmia a relatively infrequent manifestation.
However, as illustrated by this case, severe arrhyth-
mias can develop. At physiological levels, calcium has
little eﬀect upon the resting membrane potential of
excitable tissues. However, in hypercalcaemia, phase
two of the cardiac action potential may shorten, the
QT interval may narrow and both cardiac conduc-
tion velocity and refractory period diminish.
Hypercalcaemia> 3.4mmol/L may produce second-
or third-degree atrio-ventricular block.2 This com-
bination of increased excitability and decreased
refractoriness may facilitate re-entry phenomena
and complex ventricular arrhythmias.3 As illustrated
by our case, severe systemic hypercalaemica may also
lead to intracellular and extracellular calcium depos-
ition, including in cardiac myocytes which further
increases the risk of arrhythmias. In addition, hyper-
calcaemia can impact upon cardiac contraction and
myocardial relaxation, an observation similar to that
seen with dialysis against both low- and high-
calcium-containing ﬂuids.4
In our patient, the underlying pathology and cause
of severe arrhythmia were not identiﬁed until post-
mortem; extensive intra- and extracellular calcium
deposition in her myocardium and other organs
due to ATLL with widespread inﬁltration of
lymph nodes, bone marrow, lungs and liver were
seen. Interestingly, pre-mortem examination of
her peripheral blood ﬁlm did not reveal any malig-
nant cells.
Table 1. Serial laboratory results.
Result
Day of
admission
to hospital Day 1 Day 2 Day 3 Day 6
Hb (g/L) 113 111 101 93 107
WCC (109) 19.8 24.6 19.4 21.1 34.3
Neutrophils
(109)
17.6 21.9 16.9 190 31.6
Platelets
(109)
225 217 170 157 192
Sodium
(mmol/L)
134 133 144 145 138
Potassium
(mmol/L)
5.0 4.7 4.2 4.6 6.4
Urea
(mmol/L)
22.1 24.2 – 15.9 –
Creatinine
(mmol/L)
301 322 249 203 188
HCO3
(mmol/L)
22 21 30 31 15
Cl (mmol/L) 97 102 101 105 100
Corrected
calcium
(mmol/L)
4.56 4.74 4.38 4.26 3.32
Phosphate
(mmol/L)
2.2 2.1 2.1 24 2.8
Magnesium
(mmol/L)
1.03 1.45 0.97 1.03 2.34
Bilirubin
(mmol/L)
8 8 4 4 6
ALT (IU/L) 59 51 38 48 70
ALP (IU/L) 163 153 139 130 175
C-reactive
protein
(mg/L)
336 335 233 214 232
Albumin
(g/dL)
26 23 20 20 19
Urine
protein/
creatinine
ratio
(mg protein/
mmol
creatinine)
1491 – – – –
WBC: white blood cell count; Hb: haemoglobin; ALT: alanine
transaminase; ALP: alkaline phosphatase.
Figure 1. Calcium deposition in coronary arteries
(arrow) and cardiac myocytes (chevron) (von Kossa stain).
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ATLL is a rare aggressive form of non-Hodgkin’s
lymphoma.5,6 It is classiﬁed into four major subtypes:
smouldering, chronic, lymphomatous and leu-
kaemic.4 Therapeutic options are limited although
partial eﬀectiveness has been seen with regimens
such as rituximab/cyclophosphamide/doxorubicin/
vincristine/prednisolone. Median survival is around
6–12 months.5
ChronicHTLV-1 infection is a known risk factor for
ATLL. HTLV-1 was discovered in the 1980s, and the
ﬁrst retrovirus described in humans. It is ubiquitous
across the world but endemic to South West Japan.7
As with all retroviruses, cellular infection is permanent.
Transmission of the virus is similar to human immuno-
deﬁciency virus but early-life exposure (usually vertical
transmission during lactation) seems to be of particular
relevance to the development of ATLL.5
Hypercalcaemia is a prominent ﬁnding in 70–80%
of patients with ATLL.8 The underlying mechanisms
are related to direct or indirect osteoclast activation
mainly due to PTH-related peptide and pro-inﬂam-
matory cytokines and chemokines.7,9,10 In the setting
of ATLL, systemic hypercalcaemia can lead to exten-
sive calciﬁcation.10 Based on the clinical presentation,
biochemical results and histological ﬁndings, we pos-
tulate that the combination of systemic hypercalcae-
mia and prodigious myocyte calciﬁcation together
with pro-inﬂammatory processes produced refractory
cardiovascular instability which explains our patient’s
rapid demise.
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